Uptake of Biosimilars and Its Economic Implication for the Treatment of Patients with Rheumatoid Arthritis in Korea

BACKGROUND: We aimed to examine the uptake of infliximab and etanercept biosimilars in patients with rheumatoid arthritis (RA) and its economic implication for healthcare expenditure. METHODS: Using Korean Health Insurance Review and Assessment Service National Patient Samples, we extracted RA patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Soo-Kyung, Jung, Sun-Young, Kim, Hyoungyoung, Song, Yeo-Jin, Lee, Kyungeun, Sung, Yoon-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144596/
https://www.ncbi.nlm.nih.gov/pubmed/34032032
http://dx.doi.org/10.3346/jkms.2021.36.e143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144596/
https://www.ncbi.nlm.nih.gov/pubmed/34032032
http://dx.doi.org/10.3346/jkms.2021.36.e143

Ejemplares similares